ANGELA COMPTON: Open Payments
NPI 1619962040 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 38 payments from 14 companies in 2025. Trend: 2023 $1,477 · 2024 $1,296 · 2025 $803
Food & beverage: $628Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $327 |
| Amgen Inc. | 2 | $184 |
| Lilly USA, LLC | 5 | $76 |
| Novo Nordisk Inc | 2 | $33 |
| Dexcom, Inc. | 2 | $29 |
| Organon LLC | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: VRAYLAR, PROLIA, MOUNJARO, UBRELVY, QULIPTA, Dexcom G6 Transmitter, NEXPLANON, FARXIGA.
Industry payments across CO — which companies pay providers there.
